logo
16:01 Feb 26

Ambalal Sarabhai Enterprises Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
26.30
-0.30 (-1.13%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd. Financials

Ambalal Sarabhai Enterprises Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
26.30
-0.30 (-1.13%)
16:01 Feb 26
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

29/100
Technically Bearish

Strength

7

Weakness

9

Opportunity

0

Threats

0

3.52 %

ROE %

1.82 %

ROA %

1.44

EPS

18.26

BVPS

2.51 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
196.75 170.28 173.57 196.19 201.6
Operating Expenses +
171.85 161.71 167.25 188.11 190.1
Raw Material
114.07 105.24 98.62 121.48 120.81
Increase Decrease in Cost
0.64 -2.38 2.4 -5.98 -0.68
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
25.3 25.33 27.7 30.7 31.8
Miscellaneous Expenses
234.52 217.84 205.35 245.83 38.17
Operating Profit
24.9 8.57 6.32 8.08 11.5
Other Income
42.02 12.49 10.37 11.38 14.19
Depreciation
2.32 2.76 3.57 4.01 3.92
Interest
1.7 2.44 3.76 4.26 3.63
Profit before tax and exceptio..
62.89 15.87 9.36 11.19 18.14
Exceptional Items
-15.11 0 0 -7 -7.82
PBT
47.77 15.87 9.36 4.19 25.96
Provision for Taxation
6.98 3.72 0.97 -0.1 -0.83
Net Profit
40.8 12.14 8.39 4.29 11.14
NET Profit after MI
47.22 11.1 5.68 4.93 11.03
EPS
6.16 1.45 0.74 0.64 1.36
Operating Profit Margin (%)
12.66 5.03 3.64 4.12 5.7
Net Profit Margin (%)
24 6.52 3.27 2.51 5.47

Ambalal Sarabhai Enterprises Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 31.40 31.40 31.40 31.40 31.40 31.40
FII 0.30 0.30 0.40 0.40 0.00 0.00
Public 0.00 0.00 0.00 0.10 0.10 0.00
Others 68.30 68.30 68.20 68.10 68.50 68.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: